Opioid-Maker Charged With Fraud In Marketing Drug As Less Prone To Abuse
NPROpioid-Maker Charged With Fraud In Marketing Drug As Less Prone To Abuse Enlarge this image Eamon Queeney/The Washington Post/Getty Images Eamon Queeney/The Washington Post/Getty Images Federal prosecutors late Tuesday charged British drugmaker Indivior with felony fraud and conspiracy for its marketing of opioid products including Suboxone. The company allegedly created a "nationwide scheme" in the U.S. designed to convince doctors and government insurance providers that Indivior's patented opioid medications are safer and less prone to abuse than cheaper generic alternatives. "The indictment alleges that, rather than marketing its opioid-addiction drug responsibly, Indivior promoted it with a disregard for the truth about its safety and despite known risks of diversion and abuse," said Assistant Attorney General Jody Hunt in a statement. Sponsor Message Federal prosecutors claim Indivior bilked Medicare, Medicaid and other health care providers out of billions of dollars as they paid for a more expensive version of the drug, believing it to be safer.